Open access
Open access
Powered by Google Translator Translator

General Interest

Editorial: Shielding from Covid-19 Should be Stratified by Risk

29 May, 2020 | 03:34h | UTC

Shielding from covid-19 should be stratified by risk – The BMJ


Study in a Cruise Boat Showed 81% of Patients Infected with Covid-19 were Asymptomatic

29 May, 2020 | 03:31h | UTC

COVID-19: in the footsteps of Ernest Shackleton – Thorax

Commentaries: New Paper Finds Startling Number Of Asymptomatic Covid-19 Carriers – Forbes AND Asymptomatic COVID-19 cases may be more common than suspected – NBC News AND Cruise ship study hints at many ‘silent’ COVID-19 infections – The BMJ


Perspective: For Seniors, COVID-19 Sets Off A Pandemic Of Despair

29 May, 2020 | 03:23h | UTC

For Seniors, COVID-19 Sets Off A Pandemic Of Despair – Kaiser Health News


Wastewater Testing Gains Traction as a Covid-19 Early Warning System

29 May, 2020 | 03:22h | UTC

Wastewater testing gains traction as a Covid-19 early warning system – STAT

Related: SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area – Water Research AND New Research Examines Wastewater to Detect Community Spread of Covid-19


Opinion: Ethical Guidelines for Deliberately Infecting Volunteers with COVID-19 to Speed Vaccine Development

29 May, 2020 | 03:19h | UTC

Ethical guidelines for deliberately infecting volunteers with COVID-19 – Journal of Medical Ethics

Commentary: COVID-19 vaccine development: New guidelines for ethical approach to infecting trial volunteers – University of Warwick

Related: Challenge trials can speed development of a Covid-19 vaccine. Planning for them needs to start now – STAT AND AstraZeneca says it may consider exposing vaccine trial participants to virus – Reuters


Face Coverings for the Public: Laying Straw Men to Rest, by Trisha Greenhalgh

28 May, 2020 | 09:57h | UTC

Face coverings for the public: Laying straw men to rest – Journal of Evaluation in Clinical Practice

Related: Face coverings for the lay public: an alternative view – CEBM Oxford AND Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach – Annals of Internal Medicine



Perspective: “The Unexpected Side Effect of Covid-19″

28 May, 2020 | 09:53h | UTC

The unexpected side effect of Covid-19 – CNN

“After Covid-19, if we dare imagine the day, it will be important to ask who was harmed by delayed and forgone medical care. But the severe financial strains on individuals and public budgets make it just as essential to ask who benefited from avoiding interventions with no salutatory effect.”


Study: Financial Ties Between Leaders of Influential US Professional Medical Associations and Industry

28 May, 2020 | 09:37h | UTC

Financial ties between leaders of influential US professional medical associations and industry: cross sectional study – The BMJ

Editorial: Financial relations between leaders of US medical societies and industry – The BMJ


WHO Manifesto for a Healthy Recovery from COVID-19

27 May, 2020 | 02:47h | UTC

WHO Manifesto for a healthy recovery from COVID-19 – World Health Organization


CDC Updated Guidance: When You Can be Around Others After You Had or Likely Had COVID-19

27 May, 2020 | 02:37h | UTC

When You Can be Around Others After You Had or Likely Had COVID-19 – Centers for Disease Control and Prevention

“I think or know I had COVID-19, and I had symptoms.”

You can be with others after:

  • 3 days with no fever AND
  • Symptoms improved AND
  • 10 days since symptoms first appeared”


Perspective: Fast and Frugal Innovations in Response to the COVID-19 Pandemic

27 May, 2020 | 02:33h | UTC

Fast and frugal innovations in response to the COVID-19 pandemic – Nature Medicine


Related Commentary on Twitter


Perspective: The Totality of the Evidence, by Dr. John Ioannidis

27 May, 2020 | 02:29h | UTC

The Totality of the Evidence – Boston Review

See other interesting perspectives from the Boston Review: Models v. Evidence AND Good Science Is Good Science

“Given what we know now, it is reasonable to consider alternatives to population-wide lockdown, even as we focus on protecting those most at risk and support health care systems to care for patients who are sick.”


Reasons to Worry Less About the Explosion of Preprints

27 May, 2020 | 02:24h | UTC

Reasons to Worry Less About the Explosion of Preprints – Absolutely Maybe Blog


Perspective: In Pandemic, Many Seeing Upsides to Telemedicine

26 May, 2020 | 09:52h | UTC

Part I: In pandemic, many seeing upsides to telemedicine – CIDRAP

Part II: COVID-19 reveals telehealth barriers, solutions – CIDRAP


Perspective: “Here’s What Needs to Happen Before We Can All Get Vaccinated for COVID-19”

26 May, 2020 | 09:45h | UTC

Here’s what needs to happen before we can all get vaccinated for COVID-19 – CBC


Study: Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients

26 May, 2020 | 09:43h | UTC

Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the “Gabrin sign” – Journal of the American Academy of Dermatology


WHO Pauses Hydroxychloroquine Arm Of COVID-19 Clinical Trial Due to Safety Concerns

26 May, 2020 | 09:35h | UTC

WHO Pauses Hydroxychloroquine Arm Of COVID-19 Clinical Trial – After Lancet Study Finds Higher Mortality Rate Among Patients Getting The Drug – Health Policy Watch

See also: WHO halts hydroxychloroquine trial for coronavirus amid safety fears – The Guardian AND WHO Halts Hydroxychloroquine Trial Over Safety Concerns – NPR


Opinion: The ‘Just Stay Home’ Message Will Backfire

26 May, 2020 | 09:33h | UTC

The ‘Just Stay Home’ Message Will Backfire – The Atlantic

“We need less extreme and more nuanced recommendations for navigating life during the pandemic.”


Related Commentary on Twitter


Hydroxychloroquine and Chloroquine for Covid-19: Large Observational Analysis Finds No Benefit and Possible Harm

25 May, 2020 | 02:03h | UTC

Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis – The Lancet

Commentaries: Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous? – The Lancet AND What a big new study on malaria drugs as Covid-19 treatments tells us — and what it doesn’t – STAT AND Hydroxychloroquine May Cause More Harm Than Benefit To COVID-19 Patients, Says New Lancet Study – Health Policy Watch


Opinion: Why Countries Should Stop Using Anti-malarial Drugs for COVID-19

25 May, 2020 | 02:02h | UTC

Why countries should stop using anti-malarial drugs for COVID-19 – The Conversation


Promising Early Results with New Vaccine from China in Phase I Trial

25 May, 2020 | 01:57h | UTC

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial – The Lancet

Commentaries: First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response – The Lancet AND Early Study Of Covid-19 Vaccine Developed In China Sees Mixed Results – Forbes AND Coronavirus Vaccine Shows Promising Early Results in China – The New York Times AND A Chinese biotech just published the first human data for its coronavirus vaccine candidate, supporting further trials – Business Insider AND Experts skeptical after researchers report positive vaccine results – CNN AND Two COVID-19 Vaccine Candidates Induce Immune Response In Healthy Volunteers – Health Policy Watch


Perspective: The World May Be Overestimating the Power of Vaccines

25 May, 2020 | 01:55h | UTC

The world needs Covid-19 vaccines. It may also be overestimating their power – STAT


Editorial – SARS-CoV2 Vaccines: Slow is Fast

25 May, 2020 | 01:54h | UTC

SARS-CoV2 vaccines: Slow is fast – Science


SARS-CoV-2 RNA in Wastewater Anticipated COVID-19 Occurrence in a Low Prevalence Area

25 May, 2020 | 01:47h | UTC

SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area – Water Research

Related: New Research Examines Wastewater to Detect Community Spread of Covid-19


Opinion: Ten Reasons why Immunity Passports are a Bad Idea

22 May, 2020 | 04:54h | UTC

Ten reasons why immunity passports are a bad idea – Nature

Related: Ethical and Legal Challenges of COVID-19 Immunity Certificates (articles and commentaries on the subject) AND Privileges and Immunity Certification During the COVID-19 Pandemic – JAMA AND The Ethics of COVID-19 Immunity-Based Licenses (“Immunity Passports”) – JAMA